5 (443) · $ 104.00 · In stock
Description
Novo Nordisk, Lilly see insatiable demand for weight-loss drugs - SRN News
Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe's most valuable company after it takes its 'miracle' weight loss drug to the U.K.
Ozempic: Metabolizing the market - Quartz
Novo Nordisk briefly overtakes LVMH as Europe's most valuable company - PharmaLive
Novo Nordisk became Europe's most valuable company
Novo Nordisk briefly overtakes LVMH as Europe's most valuable company
Ozempic, Wegovy, and other weight loss drugs' real business impact [Video]
Novo Nordisk sees double-digit Wegovy sales growth next year despite supply curbs
LVMH Moët Hennessy Louis Vuitton : backed fund to buy 60% of Italian fashion label Etro -sources -July 18, 2021 at 09:23 am
Novo Nordisk (NOVOB) Briefly Overtakes LVMH (MC) as Biggest European Company - Bloomberg
CHART OF THE DAY: Ozempic maker Novo Nordisk overtakes LVMH to become the biggest company in Europe